PharmaEssentia (TWSE: 6446) today announced its net revenues for December 2024: On a consolidated basis, revenues for December 2024 were approximately NT$1.17 billion, an increase of 15.60 percent from November 2024 and an increase of 73.98 percent from December 2023. The year-to-date consolidated revenue totaled NT$9.78 billion, an increase of 91.48%.
.jpg)
202412_PharmaEssentia Revenue(EN).pdf